1. Modulation of Autoimmunity and Disease: The Penicillamine Experience,1981
2. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases;Jaffe;Springer Semin. Immunopathol.,1981
3. Low dose d-penicillamine therapy in rheumatoid arthritis: a 36-week controlled multicentre trial comparing 125 mg per day, 500 mg per day and placebo—a preliminary report of the Cooperating Clinics for the Systematic Study of Rheumatic Diseases;Ward,1981
4. Hypocupremia-related hypochromic anemia during d-penicillamine treatment;Cutolo;Arthr. Rheum.,1982
5. Life threatening agranulocytosis and toxic epidermal necrolysis during low dose penicillamine therapy;Ward;Irish J. med. Sci.,1981